Adaptimmune and Genentech reached the research and licensing agreement in 2021.
Ryan Sharrow
Source link
Adaptimmune shares drop as Genentech terminates potential $3B deal
Adaptimmune and Genentech reached the research and licensing agreement in 2021.
Ryan Sharrow
Source link